Early detection of cancer.


At IMBdx, our people are our most valuable asset. We are a team with expertise in NGS laboratory experiments
and clinical NGS data analysis.
We have different cultural and educational backgrounds, but our goal is the same:
Changing the way cancer is diagnosed, treated, and viewed.
  • 김태유 MD/PhD

    Tae-You Kim MD/PhD

    Co-Founder & CEO

    • Medical oncologist at Seoul National Univ. Hospital
    • Post-doc at William Kaelin Lab, Harvard Univ.
    • Chairman, Korean Cancer Asso.
    • Post-doc, Harvard Univ. (William Kaelin Lab)
  • 방두희 PhD

    Duhee Bang PhD

    Co-Founder & Chief Scientific Advisor

    • Professor of Chemistry, Yonsei Univ.
    • Damon Runyon Foundation Fellow, George Church Lab, Harvard Univ.
    • PhD in Chemistry, Univ. of Chicagos
  • 문성태 MBA

    Peter Moon MBA

    Co-Founder & CEO

    • MBA, University of Dublin
    • Prev. senior roles at SK Innovation and Hyosung Industries
  • 조연조 BS

    Yunjo Cho BS

    COO / CFO

    • BSFS, Georgetown Univ.
    • Prev. Executive Director, Morgan Stanley Private Equity.
  • 김수연 PhD

    Su Yeon Kim PhD

    Director of Bioinformatics

    • PhD in Statistics, Univ. of Chicago
    • Prev. Associate Director of Bioinformatics, Veracyte
    • Postdoc, UC Berkeley
  • 김황필 PhD

    Hwang-Phill Kim PhD

    Director of Research

    • Former Assoc. Prof., Dept. of Molecular Medicine, SNU
    • Former Asst. Prof., SNU Cancer Research Institute
  • 임유주 MD

    Yoojoo Lim MD

    Director of CDx

    • Prev. medical oncologist at Seoul National Univ. Hospital
    • Former Asst. Prof., Seoul National Univ. Hospital